Evidence map›Paper›PMID 35203480›Full record

ArticleBiomedicines2022

Decellularized In Vitro Capillaries for Studies of Metastatic Tendency and Selection of Treatment.

Outi Huttala, Desiree Loreth, Synnöve Staff, Minna Tanner, Harriet Wikman, Timo Ylikomi

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Outi HuttalaCell Biology, Faculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland.ORCID 0000-0002-9052-7230
Desiree LorethDepartment of Tumor Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.ORCID 0000-0003-0827-149X
Synnöve StaffTays Cancer Center, Tampere University Hospital, 33520 Tampere, Finland.
Minna TannerTays Cancer Center, Tampere University Hospital, 33520 Tampere, Finland.
Harriet WikmanDepartment of Tumor Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.ORCID 0000-0001-6862-0888
Timo YlikomiCell Biology, Faculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland.
Tampere University · FIUniversität Hamburg · DETampere University Hospital · FI

Funding

Business Finland naJuliana von Wendt foundation naRelander foundation sr. na
6 · The paper itself

Abstract

Vascularization plays an important role in the microenvironment of the tumor. Therefore, it should be a key element to be considered in the development of in vitro cancer assays. In this study, we decellularized in vitro capillaries to remove genetic material and optimized the medium used to increase the robustness and versatility of applications. The growth pattern and drug responses of cancer cell lines and patient-derived primary cells were studied on decellularized capillaries. Interestingly, two distinct growth patterns were seen when cancer cells were grown on decellularized capillaries: "network" and "cluster". Network formation correlated with the metastatic properties of the cells and cluster formation was observed in non-metastatic cells. Drug responses of patient-derived cells correlated better with clinical findings when cells were cultured on decellularized capillaries compared with those cultured on plastic. Decellularized capillaries provide a novel method for cancer cell culture applications. It bridges the gap between complex 3D culture methods and traditional 2D culture methods by providing the ease and robustness of 2D culture as well as an in vivo-like microenvironment and scaffolding for 3D cultures.

Indexed as

cancerhuman adipose stromal cellshuman umbilical vein endothelial cellsmetastatic nichespatient-derived cancer cells drug screeningtumor microenvironmentvasculature

Identifiers

PMID35203480
PMCPMC8869401
OpenAlexW4210522311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.